GUMULKA JERZY purchased 344.6% of their position (33.33K shares) of CNS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/6/2024ACC: 0001683168-24-000708
+100K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
100K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+33.33K
Price / share
$0.30
Trade value
$10K
% of position
344.6%
2/1/2024
9.67K→43.01K
Total
Net shares
+33.33K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/1/2024 | P · Purchase | +33.33K | $0.30 | $10K | 344.6% | 9.67K | 43.01K |
| Total | +33.33K | $10K | ||||||
Derivative Transactions2
Series A Warrant to purchase common stock
Direct
Converts to
Common Stock
33.33K shares
Shares
+33.33K
Strike price
0.30
Held after
78.76K
Exercisable
—
2/1/2024
Series B Warrant to purchase common stock
Direct
Converts to
Common Stock
33.33K shares
Shares
+33.33K
Strike price
0.30
Held after
112.09K
Exercisable
—
2/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrant to purchase common stock Direct | Common Stock33.33K shares | 2/1/2024 | A · Award | +33.33K | 0.30 | — | 78.76K |
| Series B Warrant to purchase common stock Direct | Common Stock33.33K shares | 2/1/2024 | A · Award | +33.33K | 0.30 | — | 112.09K |